Technological advancements, global market dynamics, and patient-centric approaches are all factors driving the transformation of the parenteral drug market.
Jeff Clement, Executive Director, Technical Sales – Development and Manufacturing, PCI Pharma Service
Expands sterile capacity at Latina, Italy site for fill/finish vials and PFS; to close Wolfratshausen site and discontinue sterile manufacturing at Gronau site.